Strategic Options Update: “These options went up 50% since 9:45 this morning…”
Today's Financial News - Posted March 20, 2009
Despite hair-raising news on the future of America’s debt, the markets wrapped up the week on a squawk. But one option soared 50% after we recommended it!
by J. Christoph Amberger
Baltimore—TFN: We’ve come to the end of a rather unspectacular week. Sure, the news was filled with the Fed’s creation of more than a trillion dollars and incredible new taxes. But Wall Street could not find the momentum to move in either direction this week.
“The lack of commitment by the bulls tells me that the bears are still in charge,” writes TFN options oracle Andrew Snyder this morning. It may sound like bad news, but savvy options investors can take advantage of the action.
“That’s exactly why I recommended buying puts on one of the nation’s largest insurance-sector plays on Tuesday. As the government works to ensure all of us work for an ‘acceptable’ wage, firms like this one are going to see their revenues plummet. Over the next month, shares of this company are going to drop and our options will soar.”
Speaking of soaring, remember the company with the incredibly powerful “genetic switching” technology we told you about? If you followed our plan of attack you sure would. Our recommendation is up by over 330% so far and we have not even gotten started.
“Finally, just to prove the world of options does not take weeks or months to put profits in your pocket, the recommendation I made at 9:45 this morning is already up by more than 50%. Wait until you see what happens next week. This is going to be good!”
Here’s how you can get our TFN Strategic Trader alerts when we issue them.
*** “Three biotechs that could revolutionize medicine (and make you RICH)!” That’s a special report TFN’s own Laura Cadden has compiled and is about ready to release.
We will invite you to share in her special briefing about three small, under-priced micracap stocks that are ready to launch the next generation of cancer-fighting treatments later today.
Next Article: Under Armour: A stock just as hyped as its products
Be the first to leave a reply.
Your comments are welcome

